Literature DB >> 11061954

Hendra (equine morbillivirus)

A J Barclay1, D J Paton.   

Abstract

Hendra has been recognized in Australia as a new zoonotic disease of horses since 1994/5 and subsequent work has shown that the viral agent is endemic in certain species of fruit bat. The Hendra virus is the type species of a new genus within the sub-family Paramyxovirinae, which also contains another newly identified zoonotic bat virus, namely Nipah. It is assumed that contact with bats has led to the Hendra virus being transferred to horses on each of the three separate incidents that have been reported in the last five years. No evidence has been found for widespread subclinical infection of horses. Infected horses can develop a severe and often fatal respiratory disease characterized by dyspnoea, vascular endothelial damage and pulmonary oedema. Nervous signs may also occur. Fatal respiratory disease has been seen in cats and guinea pigs following experimentally induced infections. Transmission of the virus from horses to other horses or man seems to have taken place, but very close contact was required. Three human cases have been recognized, all in association with equine cases. There have been two human fatalities, one due to respiratory failure and the other from a delayed-onset encephalitis. A number of diagnostic methods have been developed, but great care must be taken in obtaining samples from suspected cases. Copyright 2000 Harcourt Publishers Ltd.

Entities:  

Mesh:

Year:  2000        PMID: 11061954     DOI: 10.1053/tvjl.2000.0508

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  10 in total

1.  Characterization of the Tupaia rhabdovirus genome reveals a long open reading frame overlapping with P and a novel gene encoding a small hydrophobic protein.

Authors:  Christoph Springfeld; Gholamreza Darai; Roberto Cattaneo
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

2.  Clinical outcome of henipavirus infection in hamsters is determined by the route and dose of infection.

Authors:  Barry Rockx; Douglas Brining; Joshua Kramer; Julie Callison; Hideki Ebihara; Keith Mansfield; Heinz Feldmann
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

3.  Inhibition of Henipavirus fusion and infection by heptad-derived peptides of the Nipah virus fusion glycoprotein.

Authors:  Katharine N Bossart; Bruce A Mungall; Gary Crameri; Lin-Fa Wang; Bryan T Eaton; Christopher C Broder
Journal:  Virol J       Date:  2005-07-18       Impact factor: 4.099

Review 4.  Assessment of the viral safety of antivenoms fractionated from equine plasma.

Authors:  Thierry Burnouf; Elwyn Griffiths; Ana Padilla; Salwa Seddik; Marco Antonio Stephano; José-María Gutiérrez
Journal:  Biologicals       Date:  2004-09       Impact factor: 1.856

Review 5.  Bats as a continuing source of emerging infections in humans.

Authors:  Samson Wong; Susanna Lau; Patrick Woo; Kwok-Yung Yuen
Journal:  Rev Med Virol       Date:  2007 Mar-Apr       Impact factor: 6.989

Review 6.  Horses and the risk of zoonotic infections.

Authors:  Jeff B Bender; Dean T Tsukayama
Journal:  Vet Clin North Am Equine Pract       Date:  2004-12       Impact factor: 1.792

7.  Experimental inoculation study indicates swine as a potential host for Hendra virus.

Authors:  Mingyi Li; Carissa Embury-Hyatt; Hana M Weingartl
Journal:  Vet Res       Date:  2010-01-20       Impact factor: 3.683

8.  Etiology of encephalitis in Australia, 1990-2007.

Authors:  Clare Huppatz; David N Durrheim; Christopher Levi; Craig Dalton; David Williams; Mark S Clements; Paul M Kelly
Journal:  Emerg Infect Dis       Date:  2009-09       Impact factor: 6.883

9.  Vaccines to Emerging Viruses: Nipah and Hendra.

Authors:  Moushimi Amaya; Christopher C Broder
Journal:  Annu Rev Virol       Date:  2020-09-29       Impact factor: 10.431

Review 10.  Introduction: conceptualizing and partitioning the emergence process of zoonotic viruses from wildlife to humans.

Authors:  J E Childs; J A Richt; J S Mackenzie
Journal:  Curr Top Microbiol Immunol       Date:  2007       Impact factor: 4.291

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.